Aug 16 (Reuters) - Pfizer Inc and German associate BioNtech SE have submitted initial information from an early stage trial to support utility seeking authorization of a booster dose of their COVID-19 vaccine, the drugmakers noted on Monday.
The information will even be submitted to the european drug treatments agency (EMA) and other regulatory authorities within the coming weeks, the drugmakers talked about. (Reporting through Mrinalika Roy in Bengaluru; enhancing with the aid of Sriraj Kalluvila)
0 Comments